Yang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yang Liu has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Deyou Zheng
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA
15 shared publications - Anne Tranberg Madsen
Department of Microbiology and Immunology Albert Einstein College of Medicine Bronx New York
7 shared publications - Cristina Montagna
Rutgers Cancer Institute of New Jersey 2 Department of Radiology and Oncology New Brunswick, NJ
7 shared publications - Jeffrey E. Segall
Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA
7 shared publications - Michael J. Ciesielski
Department of Neurosurgery Roswell Park Comprehensive Cancer Center Buffalo NY
7 shared publications - Mou Peng
Department of Microbiology and Immunology Albert Einstein College of Medicine Bronx New York
7 shared publications
Latest Publications
- Open Access
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
- Open Access
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods, Results, Figures 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
A pdf file for supplemental methods and data
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods, Results, Figures 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
A pdf file for supplemental methods and data
- Open Access
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods, Results, Figures 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
A pdf file for supplemental methods and data
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods, Results, Figures 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
A pdf file for supplemental methods and data
- Open Access
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Supplementary Tables 1 from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
- Open Access
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Data from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Purpose:The abundance and biological contribution of cancer-associated fibroblasts (CAF) in glioblastoma (GBM) are poorly understood. Here, we aim to uncover its molecular signature, cellular roles, and potential tumorigenesis implications.Experimental Design:We first applied single-cell RNA sequencing (RNA-seq) and bioinformatics analysis to identify and characterize stromal cells with CAF transcriptomic features in human GBM tumors. Then, we performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant GBM cells.Results:We found that CAF abundance was low but significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling using three large cohorts containing bulk RNA-seq data and clinical information. Proteomic analysis of a GBM-derived CAF line and its secretome revealed fibronectin (FN1) as a critical candidate factor mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF-conditioned media and recombinant FN1 could facilitate the migration and invasion of GBM cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of GBMs. Interestingly, cell lines resembling the proneural state responded to the CAF signaling better for the migratory and invasive phenotypes.Conclusions:Overall, this study characterized the molecular features and functional impacts of CAFs in GBM, alluding to novel cell interactions mediated by CAFs in the GBM microenvironment.
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Purpose:The abundance and biological contribution of cancer-associated fibroblasts (CAF) in glioblastoma (GBM) are poorly understood. Here, we aim to uncover its molecular signature, cellular roles, and potential tumorigenesis implications.Experimental Design:We first applied single-cell RNA sequencing (RNA-seq) and bioinformatics analysis to identify and characterize stromal cells with CAF transcriptomic features in human GBM tumors. Then, we performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant GBM cells.Results:We found that CAF abundance was low but significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling using three large cohorts containing bulk RNA-seq data and clinical information. Proteomic analysis of a GBM-derived CAF line and its secretome revealed fibronectin (FN1) as a critical candidate factor mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF-conditioned media and recombinant FN1 could facilitate the migration and invasion of GBM cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of GBMs. Interestingly, cell lines resembling the proneural state responded to the CAF signaling better for the migratory and invasive phenotypes.Conclusions:Overall, this study characterized the molecular features and functional impacts of CAFs in GBM, alluding to novel cell interactions mediated by CAFs in the GBM microenvironment.
- Open Access
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Data from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Purpose:The abundance and biological contribution of cancer-associated fibroblasts (CAF) in glioblastoma (GBM) are poorly understood. Here, we aim to uncover its molecular signature, cellular roles, and potential tumorigenesis implications.Experimental Design:We first applied single-cell RNA sequencing (RNA-seq) and bioinformatics analysis to identify and characterize stromal cells with CAF transcriptomic features in human GBM tumors. Then, we performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant GBM cells.Results:We found that CAF abundance was low but significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling using three large cohorts containing bulk RNA-seq data and clinical information. Proteomic analysis of a GBM-derived CAF line and its secretome revealed fibronectin (FN1) as a critical candidate factor mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF-conditioned media and recombinant FN1 could facilitate the migration and invasion of GBM cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of GBMs. Interestingly, cell lines resembling the proneural state responded to the CAF signaling better for the migratory and invasive phenotypes.Conclusions:Overall, this study characterized the molecular features and functional impacts of CAFs in GBM, alluding to novel cell interactions mediated by CAFs in the GBM microenvironment.
- 16 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Purpose:The abundance and biological contribution of cancer-associated fibroblasts (CAF) in glioblastoma (GBM) are poorly understood. Here, we aim to uncover its molecular signature, cellular roles, and potential tumorigenesis implications.Experimental Design:We first applied single-cell RNA sequencing (RNA-seq) and bioinformatics analysis to identify and characterize stromal cells with CAF transcriptomic features in human GBM tumors. Then, we performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant GBM cells.Results:We found that CAF abundance was low but significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling using three large cohorts containing bulk RNA-seq data and clinical information. Proteomic analysis of a GBM-derived CAF line and its secretome revealed fibronectin (FN1) as a critical candidate factor mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF-conditioned media and recombinant FN1 could facilitate the migration and invasion of GBM cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of GBMs. Interestingly, cell lines resembling the proneural state responded to the CAF signaling better for the migratory and invasive phenotypes.Conclusions:Overall, this study characterized the molecular features and functional impacts of CAFs in GBM, alluding to novel cell interactions mediated by CAFs in the GBM microenvironment.
- 7 December 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 30 (4) , 865-876
Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Purpose: The abundance and biological contribution of cancer-associated fibroblasts (CAF) in glioblastoma (GBM) are poorly understood. Here, we aim to uncover its molecular signature, cellular roles, and potential tumorigenesis implications. Experimental Design: We first applied single-cell RNA sequencing (RNA-seq) and bioinformatics analysis to identify and characterize stromal cells with CAF transcriptomic features in human GBM tumors. Then, we performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant GBM cells. Results: We found that CAF abundance was low but significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling using three large cohorts containing bulk RNA-seq data and clinical information. Proteomic analysis of a GBM-derived CAF line and its secretome revealed fibronectin (FN1) as a critical candidate factor mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF-conditioned media and recombinant FN1 could facilitate the migration and invasion of GBM cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of GBMs. Interestingly, cell lines resembling the proneural state responded to the CAF signaling better for the migratory and invasive phenotypes. Conclusions: Overall, this study characterized the molecular features and functional impacts of CAFs in GBM, alluding to novel cell interactions mediated by CAFs in the GBM microenvironment.
- 7 December 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 30 (4) , 865-876
Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Purpose: The abundance and biological contribution of cancer-associated fibroblasts (CAF) in glioblastoma (GBM) are poorly understood. Here, we aim to uncover its molecular signature, cellular roles, and potential tumorigenesis implications. Experimental Design: We first applied single-cell RNA sequencing (RNA-seq) and bioinformatics analysis to identify and characterize stromal cells with CAF transcriptomic features in human GBM tumors. Then, we performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant GBM cells. Results: We found that CAF abundance was low but significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling using three large cohorts containing bulk RNA-seq data and clinical information. Proteomic analysis of a GBM-derived CAF line and its secretome revealed fibronectin (FN1) as a critical candidate factor mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF-conditioned media and recombinant FN1 could facilitate the migration and invasion of GBM cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of GBMs. Interestingly, cell lines resembling the proneural state responded to the CAF signaling better for the migratory and invasive phenotypes. Conclusions: Overall, this study characterized the molecular features and functional impacts of CAFs in GBM, alluding to novel cell interactions mediated by CAFs in the GBM microenvironment.
- Open Access
- 7 September 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (19)
Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury
A hallmark of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases is dysregulated repair of the alveolar epithelium. The Hippo pathway effector transcription factors YAP and TAZ are implicated as essential for type 1 and type 2 alveolar epithelial cell (AT1 and AT2) differentiation in the developing lung, yet aberrant activation of YAP/TAZ is a prominent feature of the dysregulated alveolar epithelium in IPF. In these studies, we sought to define the functional role of YAP/TAZ activity during alveolar regeneration. We demonstrated that Yap and Taz were normally activated in AT2 cells shortly after injury, and deletion of Yap/Taz in AT2 cells led to pathologic alveolar remodeling, failure of AT2-to-AT1 cell differentiation, increased collagen deposition, exaggerated neutrophilic inflammation, and increased mortality following injury induced by a single dose of bleomycin. Loss of Yap/Taz activity prior to an LPS injury prevented AT1 cell regeneration, led to intraalveolar collagen deposition, and resulted in persistent innate inflammation. These findings establish that AT2 cell Yap/Taz activity is essential for functional alveolar epithelial repair and prevention of fibrotic remodeling.
- 7 September 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (19)
Open AccessEpithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury
A hallmark of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases is dysregulated repair of the alveolar epithelium. The Hippo pathway effector transcription factors YAP and TAZ are implicated as essential for type 1 and type 2 alveolar epithelial cell (AT1 and AT2) differentiation in the developing lung, yet aberrant activation of YAP/TAZ is a prominent feature of the dysregulated alveolar epithelium in IPF. In these studies, we sought to define the functional role of YAP/TAZ activity during alveolar regeneration. We demonstrated that Yap and Taz were normally activated in AT2 cells shortly after injury, and deletion of Yap/Taz in AT2 cells led to pathologic alveolar remodeling, failure of AT2-to-AT1 cell differentiation, increased collagen deposition, exaggerated neutrophilic inflammation, and increased mortality following injury induced by a single dose of bleomycin. Loss of Yap/Taz activity prior to an LPS injury prevented AT1 cell regeneration, led to intraalveolar collagen deposition, and resulted in persistent innate inflammation. These findings establish that AT2 cell Yap/Taz activity is essential for functional alveolar epithelial repair and prevention of fibrotic remodeling.